Wolfgang Jahnke studied Chemistry at the University of Tubingen (Germany) and obtained a Ph.D. degree from the University of M? with Horst Kessler in 1994. He then joined the pharmaceutical industry and is currently head of a drug discovery group at Novartis Pharma AG in Basel (Switzerland). His main expertise is on the application of NMR spectroscopy for drug discovery. In recent years, this has included the development of novel methods for fragment-based ligand design and the characterization of protein-ligand interactions.